Literature DB >> 21478160

Assessing the role of the glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) three-finger domain in binding lipoprotein lipase.

Anne P Beigneux1, Brandon S J Davies, Shelly Tat, Jenny Chen, Peter Gin, Constance V Voss, Michael M Weinstein, André Bensadoun, Clive R Pullinger, Loren G Fong, Stephen G Young.   

Abstract

Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) is an endothelial cell protein that transports lipoprotein lipase (LPL) from the subendothelial spaces to the capillary lumen. GPIHBP1 contains two main structural motifs, an amino-terminal acidic domain enriched in aspartates and glutamates and a lymphocyte antigen 6 (Ly6) motif containing 10 cysteines. All of the cysteines in the Ly6 domain are disulfide-bonded, causing the protein to assume a three-fingered structure. The acidic domain of GPIHBP1 is known to be important for LPL binding, but the involvement of the Ly6 domain in LPL binding requires further study. To assess the importance of the Ly6 domain, we created a series of GPIHBP1 mutants in which each residue of the Ly6 domain was changed to alanine. The mutant proteins were expressed in Chinese hamster ovary (CHO) cells, and their expression level on the cell surface and their ability to bind LPL were assessed with an immunofluorescence microscopy assay and a Western blot assay. We identified 12 amino acids within GPIHBP1, aside from the conserved cysteines, that are important for LPL binding; nine of those were clustered in finger 2 of the GPIHBP1 three-fingered motif. The defective GPIHBP1 proteins also lacked the ability to transport LPL from the basolateral to the apical surface of endothelial cells. Our studies demonstrate that the Ly6 domain of GPIHBP1 is important for the ability of GPIHBP1 to bind and transport LPL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21478160      PMCID: PMC3103352          DOI: 10.1074/jbc.M111.242024

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Molecular evolution and phylogeny of elapid snake venom three-finger toxins.

Authors:  B G Fry; W Wüster; R M Kini; V Brusic; A Khan; D Venkataraman; A P Rooney
Journal:  J Mol Evol       Date:  2003-07       Impact factor: 2.395

2.  GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries.

Authors:  Brandon S J Davies; Anne P Beigneux; Richard H Barnes; Yiping Tu; Peter Gin; Michael M Weinstein; Chika Nobumori; Rakel Nyrén; Ira Goldberg; Gunilla Olivecrona; André Bensadoun; Stephen G Young; Loren G Fong
Journal:  Cell Metab       Date:  2010-07-07       Impact factor: 27.287

3.  High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis.

Authors:  B C Cunningham; J A Wells
Journal:  Science       Date:  1989-06-02       Impact factor: 47.728

4.  Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide.

Authors:  Paola Llinas; Marie Hélène Le Du; Henrik Gårdsvoll; Keld Danø; Michael Ploug; Bernard Gilquin; Enrico A Stura; André Ménez
Journal:  EMBO J       Date:  2005-04-07       Impact factor: 11.598

5.  Characterization of the functional epitope on the urokinase receptor. Complete alanine scanning mutagenesis supplemented by chemical cross-linking.

Authors:  Henrik Gårdsvoll; Bernard Gilquin; Marie Hélène Le Du; Andre Ménèz; Thomas J D Jørgensen; Michael Ploug
Journal:  J Biol Chem       Date:  2006-05-03       Impact factor: 5.157

6.  Mapping part of the functional epitope for ligand binding on the receptor for urokinase-type plasminogen activator by site-directed mutagenesis.

Authors:  H Gårdsvoll; K Danø; M Ploug
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

7.  Binding of lipoprotein lipase to heparin. Identification of five critical residues in two distinct segments of the amino-terminal domain.

Authors:  A Hata; D N Ridinger; S Sutherland; M Emi; Z Shuhua; R L Myers; K Ren; T Cheng; I Inoue; D E Wilson
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

8.  Identification of a heparin-binding domain in the distal carboxyl-terminal region of lipoprotein lipase by site-directed mutagenesis.

Authors:  R A Sendak; A Bensadoun
Journal:  J Lipid Res       Date:  1998-06       Impact factor: 5.922

9.  Mutagenesis in four candidate heparin binding regions (residues 279-282, 291-304, 390-393, and 439-448) and identification of residues affecting heparin binding of human lipoprotein lipase.

Authors:  Y Ma; H E Henderson; M S Liu; H Zhang; I J Forsythe; I Clarke-Lewis; M R Hayden; J D Brunzell
Journal:  J Lipid Res       Date:  1994-11       Impact factor: 5.922

10.  Structure of a soluble, glycosylated form of the human complement regulatory protein CD59.

Authors:  C M Fletcher; R A Harrison; P J Lachmann; D Neuhaus
Journal:  Structure       Date:  1994-03-15       Impact factor: 5.006

View more
  31 in total

1.  Evidence for Two Distinct Binding Sites for Lipoprotein Lipase on Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1).

Authors:  Mart Reimund; Mikael Larsson; Oleg Kovrov; Sergo Kasvandik; Gunilla Olivecrona; Aivar Lookene
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

2.  Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.

Authors:  Anne P Beigneux; Kazuya Miyashita; Michael Ploug; Dirk J Blom; Masumi Ai; MacRae F Linton; Weerapan Khovidhunkit; Robert Dufour; Abhimanyu Garg; Maureen A McMahon; Clive R Pullinger; Norma P Sandoval; Xuchen Hu; Christopher M Allan; Mikael Larsson; Tetsuo Machida; Masami Murakami; Karen Reue; Peter Tontonoz; Ira J Goldberg; Philippe Moulin; Sybil Charrière; Loren G Fong; Katsuyuki Nakajima; Stephen G Young
Journal:  N Engl J Med       Date:  2017-04-05       Impact factor: 91.245

3.  Heterogeneity in the properties of mutant secreted lymphocyte antigen 6/urokinase receptor-related protein 1 (SLURP1) in Mal de Meleda.

Authors:  O Adeyo; M Oberer; M Ploug; L G Fong; S G Young; A P Beigneux
Journal:  Br J Dermatol       Date:  2015-08-19       Impact factor: 9.302

4.  GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia.

Authors:  Xuchen Hu; Geesje M Dallinga-Thie; G Kees Hovingh; Sandy Y Chang; Norma P Sandoval; Tiffany Ly P Dang; Isamu Fukamachi; Kazuya Miyashita; Katsuyuki Nakajima; Masami Murakami; Loren G Fong; Michael Ploug; Stephen G Young; Anne P Beigneux
Journal:  J Clin Lipidol       Date:  2017-06-13       Impact factor: 4.766

5.  Monoclonal antibodies that bind to the Ly6 domain of GPIHBP1 abolish the binding of LPL.

Authors:  Xuchen Hu; Mark W Sleeman; Kazuya Miyashita; MacRae F Linton; Christopher M Allan; Cuiwen He; Mikael Larsson; Yiping Tu; Norma P Sandoval; Rachel S Jung; Alaleh Mapar; Tetsuo Machida; Masami Murakami; Katsuyuki Nakajima; Michael Ploug; Loren G Fong; Stephen G Young; Anne P Beigneux
Journal:  J Lipid Res       Date:  2016-11-15       Impact factor: 5.922

6.  An LPL-specific monoclonal antibody, 88B8, that abolishes the binding of LPL to GPIHBP1.

Authors:  Christopher M Allan; Mikael Larsson; Xuchen Hu; Cuiwen He; Rachel S Jung; Alaleh Mapar; Constance Voss; Kazuya Miyashita; Tetsuo Machida; Masami Murakami; Katsuyuki Nakajima; André Bensadoun; Michael Ploug; Loren G Fong; Stephen G Young; Anne P Beigneux
Journal:  J Lipid Res       Date:  2016-08-05       Impact factor: 5.922

7.  Multimerization of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) and familial chylomicronemia from a serine-to-cysteine substitution in GPIHBP1 Ly6 domain.

Authors:  Wanee Plengpanich; Stephen G Young; Weerapan Khovidhunkit; André Bensadoun; Hirankorn Karnman; Michael Ploug; Henrik Gårdsvoll; Calvin S Leung; Oludotun Adeyo; Mikael Larsson; Suwanna Muanpetch; Supannika Charoen; Loren G Fong; Sathit Niramitmahapanya; Anne P Beigneux
Journal:  J Biol Chem       Date:  2014-05-20       Impact factor: 5.157

8.  High-resolution imaging of dietary lipids in cells and tissues by NanoSIMS analysis.

Authors:  Haibo Jiang; Chris N Goulbourne; Angelica Tatar; Kirsten Turlo; Daniel Wu; Anne P Beigneux; Chris R M Grovenor; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2014-08-20       Impact factor: 5.922

Review 9.  Influence of apolipoprotein A-V on the metabolic fate of triacylglycerol.

Authors:  Vineeta Sharma; Trudy M Forte; Robert O Ryan
Journal:  Curr Opin Lipidol       Date:  2013-04       Impact factor: 4.776

Review 10.  Biochemistry and pathophysiology of intravascular and intracellular lipolysis.

Authors:  Stephen G Young; Rudolf Zechner
Journal:  Genes Dev       Date:  2013-03-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.